Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma [PDF]
Frontiers in Endocrinology, 2022 ObjectiveTo evaluate the pregnancy outcomes of progestin-primed ovarian stimulation (PPOS) protocol for patients with endometrioma underwent in vitro fertilization/intra-cytoplasmic sperm injection embryo transfer (IVF/ICSI-ET).DesignObservational ...
Ai-Min Yang +12 more
doaj +4 more sources
Progestin-primed ovarian stimulation protocol in patients undergoing assisted reproductive technology [PDF]
Frontiers in Reproductive HealthPurposeTo evaluate the effectiveness and safety of the novel protocol—progestin-primed ovarian stimulation (PPOS) protocol during controlled ovarian hyperstimulation (COH), in patients undergoing in vitro fertilization/intracytopalsmic sperm injection ...
Shanqin Qi +7 more
doaj +5 more sources
Progestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation [PDF]
Scientific ReportsTo prevent the occurrence of a luteinizing hormone surge during assisted reproductive technology cycles, clinicians commonly utilize gonadotropin-releasing hormone (GnRH) analogues or progestin.
Elif Meseci +6 more
doaj +4 more sources
Effect of letrozole cotreatment in progestin-primed ovarian stimulation on IVF/ICSI outcomes in POSEIDON group 3 and 4 poor responders: a retrospective cohort study [PDF]
European Journal of Medical ResearchBackground For poor ovarian response patients, obtaining higher number of transferable and high-quality embryos is crucial and progestin-primed ovarian stimulation protocol is becoming widespread and constantly improving in this population. Letrozole has
Luyao Wang +5 more
doaj +3 more sources
Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results [PDF]
Reproductive Medicine and Biology, 2023 Purpose To investigate whether progestin‐primed ovarian stimulation (PPOS) with chlormadinone acetate (CMA) adversely affects clinical results and neonatal outcomes, or causes congenital deformities.
Sena Shibasaki +6 more
doaj +4 more sources
Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study [PDF]
BMC Women's Health, 2022 Objective To explore the efficacy of progestin-primed ovarian stimulation (PPOS) combined with clomiphene citrate (CC) versus PPOS protocol used alone on cycle characteristics and pregnancy outcomes for women with the poor ovarian response (POR). Methods
Ahui Liu +5 more
doaj +4 more sources
Progestin-primed ovarian stimulation with letrozole using different doses of medroxyprogesterone acetate per day: a retrospective cohort study [PDF]
Frontiers in EndocrinologyBackgroundIn the progestin-primed ovarian stimulation protocol, the oral administration of medroxyprogesterone acetate has been observed to effectively inhibit the LH surge during ovarian stimulation in patients experiencing infertility.
Hai-long Li +12 more
doaj +2 more sources
Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review and meta-analysis [PDF]
Frontiers in Endocrinology, 2023 Polycystic ovary syndrome (PCOS) is a common endocrinopathy causing infertility in childbearing women. Progestin-primed ovarian stimulation (PPOS) protocol has recently been used for infertile women.
Liu Yang +12 more
doaj +2 more sources
The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study [PDF]
Frontiers in Endocrinology, 2023 ObjectiveTo explore the cycle characteristics and pregnancy outcomes of progestin-primed ovarian stimulation (PPOS) using fixed versus degressive doses of medroxyprogesterone acetate (MPA) in conjunction with letrozole (LE) in infertile women by ...
Ying Zhang +45 more
doaj +2 more sources
Cumulative Live Birth Rates in Women Undergoing Progestin-Primed Ovarian Stimulation Using Medroxyprogesterone Acetate, Dydrogesterone, and Progesterone: A Retrospective Analysis [PDF]
Drug Design, Development and TherapyFenglu Wu,1 Jing Lin,2 Jing Zhang,1 Xinggang Wang,1 Jialyu Huang,3 Jiaying Lin1 1Department of Assisted Reproduction, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Center for ...
Wu F +5 more
doaj +2 more sources